These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37290896)

  • 21. Exploring COVID-19 Vaccine Attitudes among Racially and Ethnically Minoritized Communities: Community Partners' and Residents' Perspectives.
    Martinez Leal I; Njoh J; Chen TA; Foreman-Hays F; Reed BC; Haley SA; Chavez K; Reitzel LR; Obasi EM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Global inequity creates local insufficiency: A qualitative study of COVID-19 vaccine implementation challenges in low-and-middle-income countries.
    Haldane V; Ariyarajah A; Berry I; Loutet M; Salamanca-Buentello F; Upshur REG
    PLoS One; 2023; 18(2):e0281358. PubMed ID: 36780502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addressing vaccine hesitancy and resistance for COVID-19 vaccines.
    Peters MDJ
    Int J Nurs Stud; 2022 Jul; 131():104241. PubMed ID: 35489108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
    Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
    BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa.
    Bright B; Babalola CP; Sam-Agudu NA; Onyeaghala AA; Olatunji A; Aduh U; Sobande PO; Crowell TA; Tebeje YK; Phillip S; Ndembi N; Folayan MO
    Global Health; 2021 Mar; 17(1):24. PubMed ID: 33658050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries.
    Moola S; Gudi N; Nambiar D; Dumka N; Ahmed T; Sonawane IR; Kotwal A
    J Glob Health; 2021; 11():05027. PubMed ID: 34912550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ensuring Equitable Access To COVID-19 Vaccines In The US: Current System Challenges And Opportunities.
    Shen AK; Hughes Iv R; DeWald E; Rosenbaum S; Pisani A; Orenstein W
    Health Aff (Millwood); 2021 Jan; 40(1):62-69. PubMed ID: 33211542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions to increase COVID-19 vaccine uptake: a scoping review.
    Andreas M; Iannizzi C; Bohndorf E; Monsef I; Piechotta V; Meerpohl JJ; Skoetz N
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015270. PubMed ID: 35920693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Vaccination: Guidance for Ethical, Informed Consent in a National Context.
    Little DT; Šeman EI; Walsh AL
    Issues Law Med; 2021; 36(2):127-162. PubMed ID: 36629774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination for Justice-Involved Youth.
    Goldman PN; Szoko N; Lynch L; Rankine J
    Pediatrics; 2022 Apr; 149(4):. PubMed ID: 35318482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uneven power dynamics must be levelled in COVID-19 vaccines access and distribution.
    Alaran AJ; Adebisi YA; Badmos A; Khalid-Salako F; Gaya SK; Ilesanmi EB; Olaoye DQ; Bamisaiye A; Lucero-Prisno DE
    Public Health Pract (Oxf); 2021 Nov; 2():100096. PubMed ID: 33615282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The global COVID-19 vaccine surplus: tackling expiring stockpiles.
    Quan NK; Anh NLM; Taylor-Robinson AW
    Infect Dis Poverty; 2023 Mar; 12(1):21. PubMed ID: 36941709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social justice in medical education: a student-led approach to addressing COVID-19 vaccine equity in the Hispanic/Latinx community.
    Adler AV; Nadone HR; Dafinone ME; Facemyer KC
    Med Educ Online; 2023 Dec; 28(1):2241169. PubMed ID: 37499134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Communication to promote and support physical distancing for COVID-19 prevention and control.
    Ryan RE; Silke C; Parkhill A; Virgona A; Merner B; Hurley S; Walsh L; de Moel-Mandel C; Schonfeld L; Edwards AG; Kaufman J; Cooper A; Chung RKY; Solo K; Hellard M; Di Tanna GL; Pedrana A; Saich F; Hill S
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015144. PubMed ID: 37811673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparative Analysis on the Social Determinants of COVID-19 Vaccination Coverage in Fragile and Conflict Affected Settings and Non-fragile and Conflict Affected Settings.
    Pattanshetty S; Pardesi M; Gudi N
    Int J Health Policy Manag; 2023; 12():6830. PubMed ID: 36300252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syringes must be prioritized globally to ensure equitable access to COVID-19 and other essential vaccines and to sustain safe injection practices.
    Fritz J; Griffin E; Hammack R; Herrick T; Jarrahian C
    Hum Vaccin Immunother; 2022 Dec; 18(7):2077580. PubMed ID: 35648471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa.
    Kana BD; Arbuthnot P; Botwe BK; Choonara YE; Hassan F; Louzir H; Matsoso P; Moore PL; Muhairwe A; Naidoo K; Ndomondo-Sigonda M; Madhi SA
    Lancet Infect Dis; 2023 Aug; 23(8):e288-e300. PubMed ID: 37290473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
    Hunter CM; Chou WS; Webb Hooper M
    Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global justice and the COVID-19 vaccine: Limitations of the public goods framework.
    Saksena N
    Glob Public Health; 2021; 16(8-9):1512-1521. PubMed ID: 33764847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.